Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioMark Diagnostics Inc C.BUX

Alternate Symbol(s):  BMKDF

BioMark Diagnostics Inc. is a liquid biopsy company. The Company is developing a molecular diagnostics technology platform, which leverages the power of metabolomics and machine learning algorithms to bring new cancer diagnostics to market and improve cancer prognosis by allowing physicians to detect carcinomas in the pre-symptomatic stages. The technology can also be used for measuring response to treatment and potentially for serial monitoring of cancer survivors. Its cancer diagnostics technology platform leverages Omics and machine learning with a focus on cancers that are hard to detect and treat cancers. Its liquid biopsy assay detects Spermidine/spermine N-acetyltransferase 1 (SSAT1). SSAT1 is an enzyme with elevated levels in numerous cancers. Its oncology has developed a new high powered liquid biopsy metabolic panel assay. The new metabolic assay is instrumental for early-stage diagnosis of lung cancer. The liquid biopsy metabolic panel has demonstrated clinical detections.


CSE:BUX - Post by User

Post by geodcanon Feb 27, 2023 4:54pm
116 Views
Post# 35308170

dyodd

dyoddHit the insider tab on the info banner at the top of the page and check it out for yerself!

I think it would be fair to say that insiders Bux and Huang are keeping the shareprice up for a long time.

The spike up, it seems was pretty much orchestrated by their trades and the continual support of this .20c range for the last little while.

All of that being said, I do have a bid in for 200k shares on the hope that this new tech testing that they are working on could be a gamechanger and if they can get shareholders back to buying mode.

Some positive development and more acknowledement from peers and such.

The fact that we can still raise some funding for development from certified agencies bodes well.

If they can turn this into a run-away winner and successful new technique, shareholders could go along for the ride but not just with their shareprice supports.

glta and dyodd
<< Previous
Bullboard Posts
Next >>